Woman Claims She Suffered from NuvaRing Blood Clot
By Jessica Tyner
When NuvaRing came on the market, it seemed like the perfect birth control for many women. A plastic ring that’s inserted vaginally for three weeks, it offered plenty of benefits. Because the NuvaRing released tiny amounts of hormones compared to birth control pills, it could be forgotten for three weeks and it was easy to use, many women selected it as an easy and effective method of contraception. However, the NuvaRing has also been linked to blood clotting—just like birth control pills.
Jennifer Cartmille of Ohio filed her NuvaRing lawsuit on September 28, 2013. “After being prescribed and using the NuvaRing, upon information and belief, Plaintiff suffered from a venous sinus thrombosis on or about April 29, 2011.” She claims that the manufacturers failed to warn her about the risk of dangerous NuvaRing blood clots.
Organon, the maker of the NuvaRing, is facing a number of NuvaRing lawsuits around the country. According to NuvaRing lawsuits like Cartmille’s, Organon “failed to properly disclose the known safety hazards associated with NuvaRing. The package insert accompanying NuvaRing stated that the vaginal ring is expected to be associated with similar risks to that of birth control pills and that the safety information they provide to consumers is derived primarily from studies of birth control pills.”
In her NuvaRing lawsuit, Cartmille says that, “Defendants knew, but failed to disclose that the NuvaRing had a higher risk of stroke and thromboembolic complication that the pill, due to the markedly potentiated and/or effects caused by the synthetic, third-generation progestin used in the NuvaRing. Defendants negligently and/or recklessly marketed the NuvaRing as a novel vaginal delivery system, and placed the product into the stream of commerce without conducting adequate tests to regulate the exposure and/or release rates of estrogen and Progestin to a user, including Plaintiff, of such product.” Had she known of the real NuvaRing complications, she says she could have opted for a safer form of birth control or at least be on high alert for signs of blood clots.
Taking Action
Cartmille says that “Defendants, by and through their agents, servants and/or employees, negligently, recklessly, carelessly and/or grossly negligently marketed, distributed, and/or sold NuvaRing without adequate instructions or warnings of its known serious side effects and unreasonably dangerous risks.” She is suing for defective manufacturing, defective design, inadequate warning, breach of warranty, negligence, misrepresentation and fraud, violation of Ohio consumer protection acts and successor liability. She says that she “and the medical community relied upon Defendants’ misrepresentations and omissions in determining which birth control contraceptive to prescribe.”
The NuvaRing lawsuit is Jennifer Cartmille v. Organon USA Inc., et al., Case No. 0-13-cv-02627, in the U.S. District Court for the District of Minnesota.
Did You Experience NuvaRing Blood Clots?
Did you use the NuvaRing and get a blood clot from the device? If this happened to you, you might have a NuvaRing legal claim. Find out more by visiting the NuvaRing Birth Control Class Action Lawsuit Settlement & Investigation. You’ll be able to share your story, and an attorney will contact you if you qualify for a free NuvaRing claim review.
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement
One thought on Woman Claims She Suffered from NuvaRing Blood Clot